We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Protelica Awarded Phase II SBIR Grant by the National Science Foundation

News   Jan 20, 2009

 
Protelica Awarded Phase II SBIR Grant by the National Science Foundation
 
 
Advertisement
 

RELATED ARTICLES

Team Synthesizes Safer Nonaddictive Analgesics

News

A team has discovered a new class of drugs, capable of relieving pain and reducing fever without the danger of addiction or damage to the liver or kidneys.

READ MORE

A Watched Pot Never Boils… But That’s Not the Case With DNA

News

Liquid droplets formed from DNA display a peculiar response to enzymes. An international collaboration has now been able to explain the mechanisms behind bubble formation.

READ MORE

How Uromodulin Helps Against Urinary Tract Infections

News

The exact process by which uromodulin prevents inflammation had never been understood. Now an interdisciplinary team, drawn from three research groups at ETH Zurich together with researchers from the University of Zurich and the Children's Hospital Zurich, has filled this knowledge gap.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Informatics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE